摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-fluorochroman-4-ol | 917248-49-8

中文名称
——
中文别名
——
英文名称
7-fluorochroman-4-ol
英文别名
3,4-dihydro-7-fluoro-4-hydroxy-2H-1-benzopyran;7-fluoro-3,4-dihydro-2H-chromen-4-ol
7-fluorochroman-4-ol化学式
CAS
917248-49-8
化学式
C9H9FO2
mdl
——
分子量
168.168
InChiKey
IQEYDZJEDYEEBL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    29.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    7-fluorochroman-4-ol吡啶氯化亚砜 作用下, 以 乙醚 为溶剂, 反应 3.0h, 以100%的产率得到4-chloro-7-fluorochromane
    参考文献:
    名称:
    WO2006/134460
    摘要:
    公开号:
  • 作为产物:
    描述:
    7-氟苯并二氢吡喃-4-酮 在 sodium borohydrid 作用下, 以 甲醇乙酸乙酯 为溶剂, 生成 7-fluorochroman-4-ol
    参考文献:
    名称:
    3-(benzofuran-7-yl)-6-haloalkyluracils
    摘要:
    Herbicidal 3-(苯并呋喃-7-基)-6-卤代烷基尿嘧啶的化学式为##STR1##其中M为氟烷基(C.sub.1-6);D为氢、烷基(C.sub.1-6)或烷氧基(C.sub.1-6)-羰基;E为氢或烷基(C.sub.1-6),或D和E一起为--CH.sub.2 CH.sub.2 --;R为氢、氨基、烷基(C.sub.1-6)、2-烯基(C.sub.3-6)、2-炔基(C.sub.3-6)、烷氧基(C.sub.1-6)甲基、苄基、氨基、氟烷基(C.sub.1-6)、烷氧基(C.sub.1-6)-羰基甲基;或氰基烷基(C.sub.1-6),最好是具有一个氰基;X为氢、氟、氯、溴、氰基、烷基(C.sub.1-6)、卤代烷基(C.sub.1-6)、卤代烷氧基(C.sub.1-6)或烷氧基(C.sub.1-6);Y为氢、烷基(C.sub.1-6)、氟、氯或溴;Z为CH.sub.2、C.dbd.O、C.dbd.S、--CH(OH)--、--CH.sub.2 CH.sub.2 --、--CH.dbd.CH--、--(C.dbd.O)CH.sub.2 --;或C.dbd.N--O--R',其中R'为烷基(C.sub.1-6)。
    公开号:
    US05521147A1
点击查看最新优质反应信息

文献信息

  • 3-(benzofuran-7-yl)-6-haloalkyluracils
    申请人:FMC Corporation
    公开号:US05521147A1
    公开(公告)日:1996-05-28
    Herbicidal 3-(benzofuran-7-yl)-6-haloalkyluracils of the formula ##STR1## in which M is fluoroalkyl (C.sub.1-6); D is hydrogen, alkyl (C.sub.1-6), or alkoxy(C.sub.1-6)-carbonyl; E is hydrogen or alkyl (C.sub.1-6), or D and E taken together are --CH.sub.2 CH.sub.2 --; R is hydrogen, amino, alkyl (C.sub.1-6), 2-alkenyl (C.sub.3-6), 2-alkynyl (C.sub.3-6), alkoxy(C.sub.1-6)methyl, benzyl, amino, fluoroalkyl (C.sub.1-6), alkoxy (C.sub.1-6)-carbonylmethyl; or cyanoalkyl (C.sub.1-6) having preferably one cyano group; X is hydrogen, fluorine, chlorine, bromine, cyano, alkyl(C.sub.1-6), haloalkyl(C.sub.1-6), haloalkoxy(C.sub.1-6), or alkoxy(C.sub.1-6); Y is hydrogen, alkyl (C.sub.1-6), fluorine, chlorine, or bromine; and Z is CH.sub.2, C.dbd.O, C.dbd.S, --CH(OH)--, --CH.sub.2 CH.sub.2 --, --CH.dbd.CH--, --(C.dbd.O)CH.sub.2 --; or C.dbd.N--O--R' wherein R' is alkyl(C.sub.1-6).
    Herbicidal 3-(苯并呋喃-7-基)-6-卤代烷基尿嘧啶的化学式为##STR1##其中M为氟烷基(C.sub.1-6);D为氢、烷基(C.sub.1-6)或烷氧基(C.sub.1-6)-羰基;E为氢或烷基(C.sub.1-6),或D和E一起为--CH.sub.2 CH.sub.2 --;R为氢、氨基、烷基(C.sub.1-6)、2-烯基(C.sub.3-6)、2-炔基(C.sub.3-6)、烷氧基(C.sub.1-6)甲基、苄基、氨基、氟烷基(C.sub.1-6)、烷氧基(C.sub.1-6)-羰基甲基;或氰基烷基(C.sub.1-6),最好是具有一个氰基;X为氢、氟、氯、溴、氰基、烷基(C.sub.1-6)、卤代烷基(C.sub.1-6)、卤代烷氧基(C.sub.1-6)或烷氧基(C.sub.1-6);Y为氢、烷基(C.sub.1-6)、氟、氯或溴;Z为CH.sub.2、C.dbd.O、C.dbd.S、--CH(OH)--、--CH.sub.2 CH.sub.2 --、--CH.dbd.CH--、--(C.dbd.O)CH.sub.2 --;或C.dbd.N--O--R',其中R'为烷基(C.sub.1-6)。
  • Chromane Substituted Benzimidazole Derivatives as Acid Pump Antagonists
    申请人:Koike Hiroki
    公开号:US20080214519A1
    公开(公告)日:2008-09-04
    This invention relates to compounds of the formula (I): or a pharmaceutically acceptable salt thereof, wherein: A, B, X, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 , R 7 , R 8 and R 9 are each as described herein or a pharmaceutically acceptable salt, and compositions containing such compounds and the use of such compounds in the treatment of a condition mediated by acid pump antagonistic activity such as, but not limited to, as gastrointestinal disease, gastroesophageal disease, gastroesophageal reflux disease (GERD), peptic ulcer, gastric ulcer, duodenal ulcer, NSAID-induced ulcers, gastritis, infection of Helicobacter pylori, dyspepsia, functional dyspepsia, Zollinger-Ellison syndrome, non-erosive reflux disease (NERD), visceral pain, heartburn, nausea, esophagitis, dysphagia, hypersalivation, airway disorders or asthma.
    本发明涉及式(I)的化合物或其药学上可接受的盐,其中:A、B、X、R1、R2、R3、R4、R5和R6、R7、R8和R9分别如本文所述或其药学上可接受的盐,以及包含这种化合物的组合物以及在治疗由酸泵拮抗活性介导的疾病,如但不限于胃肠疾病、胃食管疾病、胃食管反流病(GERD)、消化性溃疡、胃溃疡、十二指肠溃疡、NSAID诱导性溃疡、胃炎、幽门螺杆菌感染、消化不良、功能性消化不良、佐林格-埃里森综合症、非侵蚀性反流性疾病(NERD)、内脏疼痛、心口灼热、恶心、食管炎、吞咽困难、多口水、气道障碍或哮喘等疾病中使用这种化合物的用途。
  • Chromane substituted benzimidazole derivatives as acid pump antagonists
    申请人:RaQualia Pharma Inc.
    公开号:US07718809B2
    公开(公告)日:2010-05-18
    This invention relates to compounds of the formula (I): or a pharmaceutically acceptable salt thereof, wherein: A, B, X, R1, R2, R3, R4, R5 and R6, R7, R8 and R9 are each as described herein or a pharmaceutically acceptable salt, and compositions containing such compounds and the use of such compounds in the treatment of a condition mediated by acid pump antagonistic activity such as, but not limited to, as gastrointestinal disease, gastroesophageal disease, gastroesophageal reflux disease (GERD), peptic ulcer, gastric ulcer, duodenal ulcer, NSAID-induced ulcers, gastritis, infection of Helicobacter pylori, dyspepsia, functional dyspepsia, Zollinger-Ellison syndrome, non-erosive reflux disease (NERD), visceral pain, heartburn, nausea, esophagitis, dysphagia, hypersalivation, airway disorders or asthma.
    本发明涉及公式(I)的化合物或其药学上可接受的盐,其中:A、B、X、R1、R2、R3、R4、R5和R6、R7、R8和R9各自如本文所述或其药学上可接受的盐,并且包含这种化合物的组合物以及在治疗由酸泵拮抗活性介导的疾病中使用这种化合物,例如但不限于胃肠道疾病、胃食管疾病、胃食管反流病(GERD)、消化性溃疡、胃溃疡、十二指肠溃疡、NSAID诱导性溃疡、胃炎、幽门螺杆菌感染、消化不良、功能性消化不良、佐林格-埃里森综合征、非侵蚀性反流病(NERD)、内脏疼痛、心灼热、恶心、食管炎、吞咽困难、过度流涎、气道疾病或哮喘。
  • WO2008/151927
    申请人:——
    公开号:——
    公开(公告)日:——
  • CHROMANE SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS ACID PUMP ANTAGONISTS
    申请人:RaQualia Pharma Inc
    公开号:EP1893197B1
    公开(公告)日:2009-09-09
查看更多